» Articles » PMID: 38269535

Helping Patients Understand Multi-cancer Early Detection Tests: a Scoping Review

Overview
Journal Per Med
Date 2024 Jan 25
PMID 38269535
Authors
Affiliations
Soon will be listed here.
Abstract

Multi-cancer early detection tests are emerging as a revolutionary technology for the early detection of dozens of cancers from a single blood sample, including cancers without proven screening methods. However, they also come with challenges, including false-positive and false-negative results. To help patients make informed decisions, patient education materials are crucial. A review of available materials reveals that, while some materials provide understandable and actionable information, most lack a balanced presentation of the current benefits and risks of multi-cancer early detection testing. The dynamic nature of this field necessitates continuous updates to educational materials, incorporating current evidence and uncertainties.

Citing Articles

Intention to have blood-based multi-cancer early detection (MCED) screening: a cross-sectional population-based survey in England.

Schmeising-Barnes N, Waller J, Marlow L Br J Cancer. 2024; 131(7):1202-1211.

PMID: 39191895 PMC: 11443085. DOI: 10.1038/s41416-024-02822-4.